Copyright Reports & Markets. All rights reserved.

Global Gene Therapy for Inherited Genetic Disorders Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Eye Disorders
      • 1.4.3 Hematological Disorders
      • 1.4.4 Central Nervous System Disorders
      • 1.4.5 Muscular Disorders
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global Gene Therapy for Inherited Genetic Disorders Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Research Institute
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Gene Therapy for Inherited Genetic Disorders Market Size
    • 2.2 Gene Therapy for Inherited Genetic Disorders Growth Trends by Regions
      • 2.2.1 Gene Therapy for Inherited Genetic Disorders Market Size by Regions (2019-2025)
      • 2.2.2 Gene Therapy for Inherited Genetic Disorders Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Gene Therapy for Inherited Genetic Disorders Market Size by by Players
      • 3.1.1 Global Gene Therapy for Inherited Genetic Disorders Revenue by by Players (2014-2019)
      • 3.1.2 Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio (CR5 and HHI)
    • 3.2 Gene Therapy for Inherited Genetic Disorders Key Players Head office and Area Served
    • 3.3 Key Players Gene Therapy for Inherited Genetic Disorders Product/Solution/Service
    • 3.4 Date of Enter into Gene Therapy for Inherited Genetic Disorders Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Gene Therapy for Inherited Genetic Disorders Market Size by Type (2014-2019)
    • 4.2 Global Gene Therapy for Inherited Genetic Disorders Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
    • 5.2 Gene Therapy for Inherited Genetic Disorders Key Players in North America
    • 5.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type
    • 5.4 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application

    6 Europe

    • 6.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
    • 6.2 Gene Therapy for Inherited Genetic Disorders Key Players in Europe
    • 6.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type
    • 6.4 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application

    7 China

    • 7.1 China Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
    • 7.2 Gene Therapy for Inherited Genetic Disorders Key Players in China
    • 7.3 China Gene Therapy for Inherited Genetic Disorders Market Size by Type
    • 7.4 China Gene Therapy for Inherited Genetic Disorders Market Size by Application

    8 Japan

    • 8.1 Japan Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
    • 8.2 Gene Therapy for Inherited Genetic Disorders Key Players in Japan
    • 8.3 Japan Gene Therapy for Inherited Genetic Disorders Market Size by Type
    • 8.4 Japan Gene Therapy for Inherited Genetic Disorders Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
    • 9.2 Gene Therapy for Inherited Genetic Disorders Key Players in Southeast Asia
    • 9.3 Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size by Type
    • 9.4 Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size by Application

    10 India

    • 10.1 India Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
    • 10.2 Gene Therapy for Inherited Genetic Disorders Key Players in India
    • 10.3 India Gene Therapy for Inherited Genetic Disorders Market Size by Type
    • 10.4 India Gene Therapy for Inherited Genetic Disorders Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Gene Therapy for Inherited Genetic Disorders Market Size (2014-2019)
    • 11.2 Gene Therapy for Inherited Genetic Disorders Key Players in Central & South America
    • 11.3 Central & South America Gene Therapy for Inherited Genetic Disorders Market Size by Type
    • 11.4 Central & South America Gene Therapy for Inherited Genetic Disorders Market Size by Application

    12 International Players Profiles

    • 12.1 BioMarin Pharmaceutical Inc.
      • 12.1.1 BioMarin Pharmaceutical Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Gene Therapy for Inherited Genetic Disorders Introduction
      • 12.1.4 BioMarin Pharmaceutical Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2014-2019))
      • 12.1.5 BioMarin Pharmaceutical Inc. Recent Development
    • 12.2 bluebird bio Inc.
      • 12.2.1 bluebird bio Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Gene Therapy for Inherited Genetic Disorders Introduction
      • 12.2.4 bluebird bio Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
      • 12.2.5 bluebird bio Inc. Recent Development
    • 12.3 Novartis AG
      • 12.3.1 Novartis AG Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Gene Therapy for Inherited Genetic Disorders Introduction
      • 12.3.4 Novartis AG Revenue in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
      • 12.3.5 Novartis AG Recent Development
    • 12.4 Orchard Therapeutics Plc
      • 12.4.1 Orchard Therapeutics Plc Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Gene Therapy for Inherited Genetic Disorders Introduction
      • 12.4.4 Orchard Therapeutics Plc Revenue in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
      • 12.4.5 Orchard Therapeutics Plc Recent Development
    • 12.5 Spark Therapeutics Inc.
      • 12.5.1 Spark Therapeutics Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Gene Therapy for Inherited Genetic Disorders Introduction
      • 12.5.4 Spark Therapeutics Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2014-2019)
      • 12.5.5 Spark Therapeutics Inc. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.
      Gene therapy has the potential to cure inherited diseases that cannot be cured using conventional drugs. It is being increasingly adopted in clinical trials because of its high efficacy and safety towards the treatment of inherited genetic disorders.
      In 2018, the global Gene Therapy for Inherited Genetic Disorders market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Gene Therapy for Inherited Genetic Disorders status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy for Inherited Genetic Disorders development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      BioMarin Pharmaceutical Inc.
      bluebird bio Inc.
      Novartis AG
      Orchard Therapeutics Plc
      Spark Therapeutics Inc.
      ...

      Market segment by Type, the product can be split into
      Eye Disorders
      Hematological Disorders
      Central Nervous System Disorders
      Muscular Disorders
      Others

      Market segment by Application, split into
      Hospital
      Clinic
      Research Institute
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Gene Therapy for Inherited Genetic Disorders status, future forecast, growth opportunity, key market and key players.
      To present the Gene Therapy for Inherited Genetic Disorders development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Gene Therapy for Inherited Genetic Disorders are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now